| Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens JA Potian, H Aviv, NM Ponzio, JS Harrison, P Rameshwar The Journal of Immunology 171 (7), 3426-3434, 2003 | 577 | 2003 |
| Oxygen saturation in the bone marrow of healthy volunteers JS Harrison, P Rameshwar, V Chang, P Bandari Blood, The Journal of the American Society of Hematology 99 (1), 394-394, 2002 | 418 | 2002 |
| Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P PS Bandari, J Qian, G Yehia, DD Joshi, PB Maloof, J Potian, HS Oh, ... Regulatory peptides 111 (1-3), 169-178, 2003 | 86 | 2003 |
| Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma TW Reichman, B Cracchiolo, J Sama, M Bryan, J Harrison, L Pliner, ... Journal of surgical oncology 90 (2), 51-56, 2005 | 73 | 2005 |
| Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. WC Nichols, SE Lyons, JS Harrison, RL Cody, D Ginsburg Proceedings of the National Academy of Sciences 88 (9), 3857-3861, 1991 | 72 | 1991 |
| The rationale for deltanoids in therapy for myeloid leukemia: Role of KSR–MAPK–C/EBP pathway GP Studzinski, X Wang, Y Ji, Q Wang, Y Zhang, A Kutner, JS Harrison The Journal of steroid biochemistry and molecular biology 97 (1-2), 47-55, 2005 | 59 | 2005 |
| High‐dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high‐risk primary breast cancer G Somlo, JH Doroshow, SJ Forman, LA Leong, KA Margolin, ... Cancer 73 (6), 1678-1685, 1994 | 55 | 1994 |
| Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis P Rameshwar, DD Joshi, P Yadav, J Qian, P Gascon, VT Chang, ... Blood, The Journal of the American Society of Hematology 97 (10), 3025-3031, 2001 | 52 | 2001 |
| Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and upregulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced … X Wang, E Gocek, V Novik, JS Harrison, M Danilenko, GP Studzinski Cell cycle 9 (22), 4542-4551, 2010 | 51 | 2010 |
| Clinical experience using vitamin D and analogs in the treatment of myelodysplasia and acute myeloid leukemia: A review of the literature JS Harrison, A Bershadskiy Leukemia research and treatment 2012 (1), 125814, 2012 | 47 | 2012 |
| Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter PS Bandari, J Qian, HS Oh, JA Potian, G Yehia, JS Harrison, ... Journal of neuroimmunology 138 (1-2), 65-75, 2003 | 43 | 2003 |
| ERK 5/MAPK pathway has a major role in 1α, 25-(OH) 2 vitamin D3-induced terminal differentiation of myeloid leukemia cells X Wang, S Pesakhov, A Weng, M Kafka, E Gocek, M Nguyen, JS Harrison, ... The Journal of steroid biochemistry and molecular biology 144, 223-227, 2014 | 40 | 2014 |
| ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells X Wang, S Pesakhov, JS Harrison, M Danilenko, GP Studzinski Journal of cellular physiology 229 (7), 856-867, 2014 | 40 | 2014 |
| Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant Q Wang, JS Harrison, M Uskokovic, A Kutner, GP Studzinski Leukemia 19 (10), 1812-1817, 2005 | 39 | 2005 |
| Umbilical cord blood transplants in adults using a combination of unexpanded and ex vivo expanded cells: Preliminary clinical observations. P Stiff, A Pecora, M Parthasarathy, R Preti, B Chen, J Douville, D Malhotra, ... Blood 92 (10), 646A-646A, 1998 | 39 | 1998 |
| Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1, 25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling F Jamshidi, J Zhang, JS Harrison, X Wang, GP Studzinski Cell Cycle 7 (7), 917-924, 2008 | 37 | 2008 |
| Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cells PS Bandari, J Qian, G Yehia, HP Seegopaul, JS Harrison, P Gascon, ... Neuropeptides 36 (1), 13-21, 2002 | 37 | 2002 |
| The hematopoietic stromal microenvironment promotes retro-virus-mediated gene transfer into hematopoietic stem cells JL Chertkov, S Jiang, JD Lutton, J Harrison, M Tiefenthaler, RD Levere, ... Stem Cells 11 (3), 218-227, 1993 | 37 | 1993 |
| Silibinin can induce differentiation as well as enhance vitamin D3‐induced differentiation of human AML cells ex vivo and regulates the levels of differentiation … J Zhang, JS Harrison, M Uskokovic, M Danilenko, GP Studzinski Hematological oncology 28 (3), 124-132, 2010 | 33 | 2010 |
| c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D X Chen-Deutsch, E Garay, J Zhang, JS Harrison, GP Studzinski Leukemia research 33 (10), 1372-1378, 2009 | 30 | 2009 |
